Cargando…
Prostaglandin E2 receptor EP1 expression in vulvar cancer
PURPOSE: In recent years, incidence of vulvar cancer has been on the rise, whereas therapeutic options are still restricted. Therefore, new prognosticators and therapeutic targets are essential. Chronic inflammation plays an important role in carcinogenesis and COX-2, and its product prostaglandin E...
Autores principales: | Buchholz, Anna, Vattai, Aurelia, Fürst, Sophie, Vilsmaier, Theresa, Zati Zehni, Alaleh, Steger, Alexander, Kuhn, Christina, Schmoeckel, Elisa, Dannecker, Christian, Mahner, Sven, Jeschke, Udo, Heidegger, Helene H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349743/ https://www.ncbi.nlm.nih.gov/pubmed/36436093 http://dx.doi.org/10.1007/s00432-022-04487-z |
Ejemplares similares
-
EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021) -
The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020) -
EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
por: Zati Zehni, Alaleh, et al.
Publicado: (2020) -
The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer
por: Zehni, Alaleh Zati, et al.
Publicado: (2021) -
MTA1 as negative prognostic marker in vulvar carcinoma
por: Wanka, Giulia, et al.
Publicado: (2023)